ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752703 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752703; 2) Community: the network communities that were significantly associated with the response to NSC 752703; 3) Molecule: the relationships between components within communities and NSC 752703; 4) MDR: the compounds that were significantly associated with the NSC 752703.

NSC Compound Enrichment Correlation
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0295480456086947 0.36766825
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.0295480456086947 0.29403554
NSC 734296 6-(3-Bromopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0295480456086947 0.42488274
NSC 736202 Indenoisoquinoline derivative 0.0295480456086947 0.48871655
NSC 736611 Null 0.0295480456086947 0.3429605
NSC 743874 Null 0.0295480456086947 0.24381019
NSC 746684 7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione 0.0295480456086947 0.37252921
NSC 748909 Chonemorphine 0.0295480456086947 0.32317418
NSC 639505 Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride 0.0303322639291198 0.33738775
NSC 684074 7H-5,6-Dithioleno[4,3-d]uracil 0.0303322639291198 0.38309554
Total:90  Current:62    [First] [Prev] [Next] [Last]